Which medication class is often initiated or continued after assessing contraindications in patients with ACS?

The medication class that is often initiated or continued after assessing contraindications in patients with Acute Coronary Syndromes (ACS) is statins. Statins play a crucial role in the management of ACS due to their ability to lower cholesterol levels, stabilize atherosclerotic plaques, and reduce inflammation, all of which can significantly improve outcomes for patients.

In patients with ACS, the benefits of statin therapy typically outweigh the risks, particularly in the setting of secondary prevention. Before initiating statin therapy, clinicians assess contraindications such as severe liver disease or active myopathy, ensuring patient safety while still reaping the cardiovascular protective benefits of statins.

While anticoagulants and beta-blockers are also important in the management of ACS, their use is often more immediate and less dependent on the evaluation of contraindications under acute circumstances. Antibiotics may be used selectively, often for specific indications like infection, rather than universally in the context of ACS. Statins, however, are a cornerstone for long-term management post-ACS.